Combining pap, hrHPV tests could drastically reduce cancer miss rates

Cytopathology researchers recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold.